1. 2020
  2. Impact of nitisinone treatment and discontinuation on the metabolome of wildtype and hereditary tyrosinemia type 1 mice

    Colemonts-Vroninks, H., Norman, B., Davison, A., Neuckermans, J., Marcélis, L., Mortier, A., De Bundel, D., Ranganath, L., Martens, G., Vanhaecke, T., Gallagher, J. & De Kock, J., 17 Apr 2020, p. FRI284.

    Research output: Unpublished contribution to conferencePosterResearch

  3. Directed protein evolution as a tool to innovate gene therapy for hereditary tyrosinemia type 1

    Neuckermans, J., Colemonts-Vroninks, H., Marcélis, L., Mertens, A., Schwaneberg, U. & De Kock, J., Mar 2020.

    Research output: Unpublished contribution to conferencePosterResearch

  4. 2019
  5. Anti-NASH Drug Development Hitches a Lift on PPAR Agonism

    Boeckmans, J., Natale, A., Rombaut, M., Buyl, K., Rogiers, V., De Kock, J., Vanhaecke, T. & Rodrigues, R., 21 Dec 2019, In : Cells. 9, 1, p. 1-20 20 p., 37.

    Research output: Contribution to journalArticleResearchpeer-review

  6. Large‐scale Production of LGR5‐positive Bipotential Human Liver Stem Cells

    Schneeberger, K., Sánchez‐Romero, N., Ye, S., van Steenbeek, F. G., Oosterhoff, L. A., Pla Palacin, I., Chen, C., van Wolferen, M. E., van Tienderen, G., Lieshout, R., Colemonts-Vroninks, H., Schene, I., Hoekstra, R., Verstegen, M. M. A., van der Laan, L. J. W., Penning, L. C., Fuchs, S. A., Clevers, H., De Kock, J., Baptista, P. M. & 1 othersSpee, B., 12 Nov 2019, (Accepted/In press) In : Hepatology.

    Research output: Contribution to journalArticleResearchpeer-review

  7. A robust bacterial assay for high-throughput screening of human 4-hydroxyphenylpyruvate dioxygenase inhibitors

    Neuckermans, J., Mertens, A., Schwaneberg, U. & De Kock, J., 2 Oct 2019, In : Scientific Reports. 9, 1, p. 14145 11 p.

    Research output: Contribution to journalArticleResearchpeer-review

  8. Transcriptomics data of a human in vitro model of non-alcoholic steatohepatitis exposed to elafibranor

    Boeckmans, J., Buyl, K., Natale, A., Vandenbempt, V., Branson, S., De Boe, V., Rogiers, V., De Kock, J., Marcelino Rodrigues, R. & Vanhaecke, T., 1 Aug 2019, In : Data in Brief. 25, p. 104093 6 p., 104093.

    Research output: Contribution to journalArticleResearchpeer-review

  9. Gain of 20q11.21 in Human Pluripotent Stem Cells Impairs TGF-β-Dependent Neuroectodermal Commitment.

    Markouli, C., Couvreu De Deckersberg, E., Regin, M., Nguyen Thi, H., Zambelli, F., Keller, A. S., Dziedzicka, D., De Kock, J., Tilleman, L., Van Nieuwerburgh, F., Franceschini, L., Sermon, K., Geens, M. & Spits, C., 9 Jul 2019, In : Stem Cell Reports. 13, 1, p. 163-176 14 p.

    Research output: Contribution to journalArticleResearchpeer-review

  10. Technological advancements for the development of stem cell-based models for hepatotoxicity testing

    Natale, A., Vanmol, K., Arslan, A., Van Vlierberghe, S., Dubruel, P., Van Erps, J., Thienpont, H., Buzgo, M., Boeckmans, J., De Kock, J., Vanhaecke, T., Rogiers, V. & Marcelino Rodrigues, R., Jul 2019, In : Archives of Toxicology. 93, 7, p. 1789-1805 7 p.

    Research output: Contribution to journalArticleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...12 Next

ID: 109517